Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine

Clinical trial NCT05373030 · UNKNOWN

Trial details

NCT number: NCT05373030
Sponsor: Zhejiang Provincial Center for Disease Control and Prevention
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization

Start date: 2022-05-14
Primary completion: 2022-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.